Is QuantumScape a Buy Now?
QuantumScape (NYSE:QS) is an innovative EV battery company that specializes…
Sell
47
ECG Quote, Financials, Valuation and Earnings
Last price:
$42.95
Seasonality move
:
--
Day range:
$38.52 - $40.25
52-week range:
$31.38 - $77.93
Dividend yield:
0%
P/E ratio:
13.55x
P/S ratio:
0.72x
P/B ratio:
4.86x
Volume:
449.5K
Avg. volume:
693.4K
1-year change:
--
Market cap:
$2.1B
Revenue:
$2.8B
EPS (TTM):
$2.97
Earnings Data
Next earnings date for ECG
May 30
2025
Most recent earnings per share
$0.67
Missed by $0.02
(Feb 11/2025)
Consensus Estimate
$0.69
(Feb 11/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ECG Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $765.5M | -- | -- | $0.64 | -- |
| 05/30/2025 | Q1 | $676.4M | -- | -- | $0.43 | -- |
| 02/11/2025 | Q4 | $674.9M | $759.6M | $0.67 | $0.69 | -$0.02 |
| 09/30/2024 | Q3 | $728M | $761M | $0.82 | $38.32 | -$37.50 |
| 06/30/2024 | Q2 | -- | $703.4M | $0.76 | -- | -- |
| 12/31/2023 | Q4 | -- | $635.7M | $0.35 | -- | -- |
Everus Construction Group Earnings Questions
-
How Much did Everus Construction Group Generate in Revenue Last Quarter?
Everus Construction Group reported $759.6M worth of top line sales in its most recent quarter.
-
Did Everus Construction Group Beat Earnings Last Quarter?
Everus Construction Group announced earnings per share of $0.67 which represents a miss of analyst forecast a $0.69 per share.
-
Is Everus Construction Group Profitable?
Everus Construction Group reported $86.3M that represents $1.68 per share over the last quarter.
-
What is the Analyst Consensus for Everus Construction Group EPS Next Year?
Everus Construction Group's earnings are forecast to decrease from $2.81 per share to $2.63 per share next year representing a decrease of -9.88%.
-
When is Everus Construction Group's Earnings Date?
Everus Construction Group's next earnings date is May 30, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Sell
50
RGC alert for May 1
Regencell Bioscience Holdings [RGC] is up 20.58% over the past day.
Sell
38
WGS alert for May 1
GeneDx Holdings [WGS] is down 6.85% over the past day.
Sell
43
VICR alert for May 1
Vicor [VICR] is down 1.28% over the past day.
